HomeMYX • ASX
Mayne Pharma Group Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 106.53M | 13.37% |
Operating expense | 68.11M | -5.80% |
Net income | -12.77M | 63.79% |
Net profit margin | -11.99 | 68.06% |
Earnings per share | — | — |
EBITDA | 12.25M | 609.78% |
Effective tax rate | -35.67% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.91M | -19.31% |
Total assets | 1.13B | -1.90% |
Total liabilities | 684.53M | 13.17% |
Total equity | 446.20M | — |
Shares outstanding | 81.25M | — |
Price to book | 1.32 | — |
Return on assets | -0.59% | — |
Return on capital | -1.38% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.77M | 63.79% |
Cash from operations | -6.52M | 54.63% |
Cash from investing | -22.50M | -166.95% |
Cash from financing | -130.00K | 98.71% |
Net change in cash | -28.18M | -439.28% |
Free cash flow | 11.93M | 1,311.33% |
Previous close
$7.26
Day range
$7.23 - $7.27
Year range
$3.74 - $7.46
Market cap
588.22M AUD
Avg Volume
879.92K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
About
Founded
2005
Website
Employees
900
